Factsheet | Download PDF
This summary provides guidance for procurement or reimbursement agencies on the cost-effectiveness of human versus analogue insulin for people living with type 1 or type 2 diabetes. It is based on the ACCISS Tool, The Value of Insulin: A Systematic Review of the Cost-effectiveness of Analogue and Human Insulin, available at: www.accisstoolkit.haiweb.org